The Global Cerebral Somatic Oximeters Market Continues To Grow Owing To the High Incidence Rate of Neurological Disorders in the World, In both Children and Adults

 

A cerebral somatic oximeter is used in cerebral somatic, which is a specialized test. Cerebral somatic oximeters are used in the field of medical imaging, to track and determine the functioning of the cerebral muscles and organs. It is an electroencephalograph (EEG) device to be used in children who are suspected of suffering from various brain-related disorders such as cerebral palsy, stroke, head injuries, multiple sclerosis, Parkinson's disease, and other disorders.

In this regard, the diagnostic devices gradually moved out of the pediatrician's office and moved into the hospital setting. Pediatric sales agents were instrumental in bringing about the development of this highly useful device, which is widely used in pediatric hospitals today. Cerebral somatic oximeters are commonly used in the hospitals, clinics, and laboratories of cardiologists, orthopedists, neurologists, and psychologists. As a result, the demand for these diagnostic products has tremendously increased as well.

The increase of neurological disorders worldwide has enhanced the growth of the global cerebral somatic oximeters market. For instance, according to CerebralPalsy.org, Cerebral Palsy gets diagnosed in 2.3 to 3.6 children out of 1000. Spastic Cerebral Palsy is the most common in these regards and makes up to around 61% to 76.9% of all the diagnosed cases. Moreover, rapid product approval by international organizations and the constant addition of products in pipelines are also augmenting the growth of the global cerebral somatic oximeters market.

These devices are used to detect the oxygen saturation of blood and the changes related to it. The changes can occur in various regions of the brain and other tissues of the body, which are placed beneath the sensors, in order to detect oxygen saturation effectively. The cerebral somatic oximeter works based on the principle of near-infrared spectroscopy. These devices are widely used in various surgeries related to neurological, and cardiovascular health. However, the high price of the equipment is the main factor, which is negatively affecting the growth of the global cerebral somatic oximeters market. 

In North America, the incidence rate of neurological disorders among both adults and children is very high and is increasing constantly, which is propelling the growth of the global cerebral somatic oximeters market. For instance, according to the Centers for Disease Control and Prevention, approximately 764,000 individuals in the United States have at least one of the symptoms indicating cerebral palsy. Over 10,000 babies are born every year with cerebral palsy and around 1200 to 1500 school-going children suffer from the disorder. Moreover, the increasing incidence rate of cardiovascular health issues among adults in the region is also boosting the growth of the market. Owing to such factors, there have been some significant industrial developments in the global cerebral somatic oximeters market. For instance, in August 2020, O3® Regional Oximetry, developed by Masimo got approved by the Food and Drug Administration for somatic applications.